12 patients entered a within patient cross over trial of 4 insulin regimens : -- twice daily semi-synthetic human soluble and insulin zinc suspension ( actrapid/monotard hm ) , twice daily porcine soluble and insulin zinc suspension ( actrapid/monotard ) , twice daily porcine soluble and isophane insulin ( velosulin/insulatard ) , and thrice daily porcine soluble insulin ( actrapid ) supplementing once daily bovine ultralente insulin ( ultratard ) .
C0021641
insulin
C0724601
porcine